Skip to main content
Top
Published in: Tumor Biology 12/2014

01-12-2014 | Research Article

Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma

Authors: Yazhen Li, Xiaoyun Ji, Zhaoliang Su, Jia Tong, Sheng Xia, Xiaobo Chen, Ping Lu, Prince Amoah Barnie, Shengjun Wang, Xinxiang Huang, Huaxi Xu

Published in: Tumor Biology | Issue 12/2014

Login to get access

Abstract

Runt-related transcription factor 3 (Runx3) is a tumor-suppressor gene and plays an important role in immune regulation, whose reduced expression may play an important role in the development and progression of gastric carcinoma. The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs). Our results showed that the expression levels of Runx3, T-bet, and IFN-γ in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN-γ in patients (p < 0.01). In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN-γ was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells. It suggested that the Runx3 and Th1-associated factors including T-bet and IFN-γ synchronization declines in gastric carcinoma may contribute to the development of cancer.
Literature
1.
go back to reference Bauer K, Porzsolt F, Henne-Bruns D. Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis. J Gastric Cancer. 2014;14:39–46.CrossRef Bauer K, Porzsolt F, Henne-Bruns D. Can perioperative chemotherapy for advanced gastric cancer be recommended on the basis of current research? A critical analysis. J Gastric Cancer. 2014;14:39–46.CrossRef
2.
go back to reference Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.CrossRef Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.CrossRef
3.
go back to reference Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, et al. Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res. 2014;2014:923135.CrossRef Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, et al. Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res. 2014;2014:923135.CrossRef
4.
go back to reference Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904–12.CrossRef Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904–12.CrossRef
5.
go back to reference Khan MM, Chatterjee S, Dwivedi VP, Pandey NK, Singh Y, Tousif S, et al. CD4+ T cell-derived novel peptide Thp5 induces interleukin-4 production in CD4+ T cells to direct T helper 2 cell differentiation. J Biol Chem. 2012;287(4):2830–5.CrossRef Khan MM, Chatterjee S, Dwivedi VP, Pandey NK, Singh Y, Tousif S, et al. CD4+ T cell-derived novel peptide Thp5 induces interleukin-4 production in CD4+ T cells to direct T helper 2 cell differentiation. J Biol Chem. 2012;287(4):2830–5.CrossRef
6.
go back to reference Yang M, Wang S, Wang S, Ma J, Xu X, Mao C, et al. Tat-mediated intracellular delivery of T-bet protein into THP-1 cells can induce Th1-type response. Immunol Invest. 2008;37(2):97–111.CrossRef Yang M, Wang S, Wang S, Ma J, Xu X, Mao C, et al. Tat-mediated intracellular delivery of T-bet protein into THP-1 cells can induce Th1-type response. Immunol Invest. 2008;37(2):97–111.CrossRef
7.
go back to reference Sharma A, Rajappa M, Satyam A, Sharma M. Cytokines (TH1 and TH2) in patients with advanced cervical cancer undergoing neoadjuvant chemoradiation: correlation with treatment response. Int J Gynecol Cancer. 2009;19(7):1269–75.CrossRef Sharma A, Rajappa M, Satyam A, Sharma M. Cytokines (TH1 and TH2) in patients with advanced cervical cancer undergoing neoadjuvant chemoradiation: correlation with treatment response. Int J Gynecol Cancer. 2009;19(7):1269–75.CrossRef
8.
go back to reference Su Z, Sun Y, Zhu H, Liu Y, Lin X, Shen H, et al. Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res. 2014;58(1):118–24.CrossRef Su Z, Sun Y, Zhu H, Liu Y, Lin X, Shen H, et al. Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res. 2014;58(1):118–24.CrossRef
9.
go back to reference Yang P, Qiu G, Wang S, Su Z, Chen J, Wang S, et al. The mutation of Th1 cell-specific T-box transcription factor may be associated with a predominant Th2 phenotype in gastric cancers. Int J Immunogenet. 2010;37:111–5.CrossRef Yang P, Qiu G, Wang S, Su Z, Chen J, Wang S, et al. The mutation of Th1 cell-specific T-box transcription factor may be associated with a predominant Th2 phenotype in gastric cancers. Int J Immunogenet. 2010;37:111–5.CrossRef
10.
go back to reference Xu Q, Meng S, Liu B, Li MQ, Li Y, Fang L, et al. MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3. Clin Exp Pharmacol Physiol. 2014;41(5):351–7.CrossRef Xu Q, Meng S, Liu B, Li MQ, Li Y, Fang L, et al. MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3. Clin Exp Pharmacol Physiol. 2014;41(5):351–7.CrossRef
11.
go back to reference Barnie PA, Zhang P, Lu P, Chen X, Su Z, Wang S, et al. CpG-oligodeoxynucleotides suppress the proliferation of A549 lung adenocarcinoma cells via toll-like receptor 9 signaling and upregulation of Runt-related transcription factor 3 expression. Biomed Rep. 2014;2(3):374–7.CrossRef Barnie PA, Zhang P, Lu P, Chen X, Su Z, Wang S, et al. CpG-oligodeoxynucleotides suppress the proliferation of A549 lung adenocarcinoma cells via toll-like receptor 9 signaling and upregulation of Runt-related transcription factor 3 expression. Biomed Rep. 2014;2(3):374–7.CrossRef
12.
go back to reference Ju X, Ishikawa TO, Naka K, Ito K, Ito Y, Oshima M. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Cancer Sci. 2014;105(4):418–24.CrossRef Ju X, Ishikawa TO, Naka K, Ito K, Ito Y, Oshima M. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Cancer Sci. 2014;105(4):418–24.CrossRef
13.
go back to reference Jain R, Gramigna V, Sanchez-Marull R, Perez-Ordoñez B. Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract. J Clin Pathol. 2009;62(7):634–7.CrossRef Jain R, Gramigna V, Sanchez-Marull R, Perez-Ordoñez B. Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract. J Clin Pathol. 2009;62(7):634–7.CrossRef
14.
go back to reference Martinez M, Ono N, Planutiene M, Planutis K, Nelson EL, Holcombe RF. Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int. 2013;13(1):80.CrossRef Martinez M, Ono N, Planutiene M, Planutis K, Nelson EL, Holcombe RF. Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy. Cancer Cell Int. 2013;13(1):80.CrossRef
15.
go back to reference Klinke II DJ, Cheng N, Chambers E. Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model. Sci Signal. 2012;5(220):ra32.CrossRef Klinke II DJ, Cheng N, Chambers E. Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model. Sci Signal. 2012;5(220):ra32.CrossRef
16.
go back to reference Li BH, Xu SB, Li F, et al. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. Cell Signal. 2012;24:718–25.CrossRef Li BH, Xu SB, Li F, et al. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. Cell Signal. 2012;24:718–25.CrossRef
17.
go back to reference J¨ohrens K, Dietel M, Anagnostopoulos I. Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2012;53:152–5.CrossRef J¨ohrens K, Dietel M, Anagnostopoulos I. Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2012;53:152–5.CrossRef
18.
go back to reference Kuss I, Hathway B, Ferris RL, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10:3755–62.CrossRef Kuss I, Hathway B, Ferris RL, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10:3755–62.CrossRef
19.
go back to reference Chen F, Wang M, Bai J, Liu Q, Xi Y, Li W, et al. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer. PLoS One. 2014;9(1):e86917.CrossRef Chen F, Wang M, Bai J, Liu Q, Xi Y, Li W, et al. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer. PLoS One. 2014;9(1):e86917.CrossRef
20.
go back to reference Lotem J, Levanon D, Negreanu V, Leshkowitz D, Friedlander G, Groner Y. Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One. 2013;8(11):e80467.CrossRef Lotem J, Levanon D, Negreanu V, Leshkowitz D, Friedlander G, Groner Y. Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One. 2013;8(11):e80467.CrossRef
21.
go back to reference Lee SH, Jeong HM, Choi JM, Cho YC, Kim TS, Lee KY, et al. Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT. Biochem Biophys Res Commun. 2009;381:214–7.CrossRef Lee SH, Jeong HM, Choi JM, Cho YC, Kim TS, Lee KY, et al. Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT. Biochem Biophys Res Commun. 2009;381:214–7.CrossRef
22.
go back to reference Leavanon D, Bernstein Y, Negreanu V, et al. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 1996;15:175–85.CrossRef Leavanon D, Bernstein Y, Negreanu V, et al. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 1996;15:175–85.CrossRef
23.
go back to reference Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med. 2009;206:51–9.CrossRef Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med. 2009;206:51–9.CrossRef
24.
go back to reference Ito Y. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP/CBF. Gene Cells. 1999;4:685–96.CrossRef Ito Y. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP/CBF. Gene Cells. 1999;4:685–96.CrossRef
25.
go back to reference Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene-sequence, structure and regulated expression. Gene. 2001;279:221–32.CrossRef Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene-sequence, structure and regulated expression. Gene. 2001;279:221–32.CrossRef
Metadata
Title
Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma
Authors
Yazhen Li
Xiaoyun Ji
Zhaoliang Su
Jia Tong
Sheng Xia
Xiaobo Chen
Ping Lu
Prince Amoah Barnie
Shengjun Wang
Xinxiang Huang
Huaxi Xu
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2532-6

Other articles of this Issue 12/2014

Tumor Biology 12/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine